The CCRI News resource

Radiopharmaceutical therapy using alpha-emitting radionuclides such as 223Ra and 225Ac is proving to be highly effective in fighting several forms of cancer. The safe and effective use of these types of drugs relies on the ability to make accurate measurements of the amount of the drug, measured clinically as the amount of radioactivity, being administered to the patient. Because of...

In the August 2023 edition of Measure for Measure in Nature Physics, Dr Carine Michotte took the readers on a journey through a condensed history of radionuclide metrology, starting from its remarkable inception in 1913 – when Marie Curie introduced the first international standard for Ra-226 at the BIPM – and spanning to activity measurement standards, logistical challenges of...

The CCRI was held at the Pavillon du Mail at the BIPM headquarters in Sèvres, France, and was well attended in person (36 participants) and additionally had online participation (30 attendees). This was the first in person meeting of the CCRI since the global pandemic was declared in 2020. The meeting was chaired by the new CCRI president JT Janssen from NPL. The following list...

The  CCRI Section II (Measurement of Radionuclides) met at the BIPM in Sèvres on 5-7 June 2023. There were 24 members and guests meeting in person, and an additional 19 total at various times virtually. The first half-day was held jointly with the KCWG(II). The main recommendations and actions from this meeting were: The opening of the BIPM(II)-K5 comparison, following the ...

The CCRI(I) was held from 1 to 2 June 2023 at the Vienna International Centre in conjunction with the IAEA SSDL (Secondary Standard Dosimetry Laboratories) Network meeting the 29 and 30 of May 2023. A Joint IAEA-SSDL CCRI(I) one day workshop was organized between the two meetings to enhance the links between the two communities. All these events provided online participation. 40...